Autolus Therapeutics (AUTL) Current Assets (2017 - 2025)
Historic Current Assets for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $514.6 million.
- Autolus Therapeutics' Current Assets fell 2834.33% to $514.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.6 million, marking a year-over-year decrease of 2834.33%. This contributed to the annual value of $660.9 million for FY2024, which is 14007.42% up from last year.
- Per Autolus Therapeutics' latest filing, its Current Assets stood at $514.6 million for Q3 2025, which was down 2834.33% from $574.2 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Current Assets peaked at $804.3 million during Q1 2024, and registered a low of $212.3 million during Q3 2022.
- In the last 5 years, Autolus Therapeutics' Current Assets had a median value of $355.4 million in 2023 and averaged $438.3 million.
- In the last 5 years, Autolus Therapeutics' Current Assets tumbled by 3534.04% in 2023 and then skyrocketed by 14007.42% in 2024.
- Autolus Therapeutics' Current Assets (Quarter) stood at $347.0 million in 2021, then increased by 22.72% to $425.8 million in 2022, then crashed by 35.34% to $275.3 million in 2023, then surged by 140.07% to $660.9 million in 2024, then decreased by 22.14% to $514.6 million in 2025.
- Its Current Assets stands at $514.6 million for Q3 2025, versus $574.2 million for Q2 2025 and $615.8 million for Q1 2025.